182 related articles for article (PubMed ID: 37081115)
1. The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway.
Liang X; Yao J; Cui D; Zheng W; Liu Y; Lou G; Ye B; Shui L; Sun Y; Zhao Y; Zheng M
Cell Death Differ; 2023 Jun; 30(6):1550-1562. PubMed ID: 37081115
[TBL] [Abstract][Full Text] [Related]
2. TRAF2 decrease promotes the TGF-β-mTORC1 signal in MAFLD-HCC through enhancing AXIN1-mediated Smad7 degradation.
Li Z; Zhao J; Wu Y; Fan S; Yuan H; Xia J; Hu L; Yang J; Liu J; Wu X; Lin R; Yang L
FASEB J; 2024 Feb; 38(4):e23491. PubMed ID: 38363556
[TBL] [Abstract][Full Text] [Related]
3. Unlocking hepatocellular carcinoma aggression: STAMBPL1-mediated TRAF2 deubiquitination activates WNT/PI3K/NF-kb signaling pathway.
Wang Z; Zhang Y; Shen Y; Zhou H; Gao Y; Zhu C; Qin X
Biol Direct; 2024 Feb; 19(1):18. PubMed ID: 38419066
[TBL] [Abstract][Full Text] [Related]
4. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling.
Wang B; Jie Z; Joo D; Ordureau A; Liu P; Gan W; Guo J; Zhang J; North BJ; Dai X; Cheng X; Bian X; Zhang L; Harper JW; Sun SC; Wei W
Nature; 2017 May; 545(7654):365-369. PubMed ID: 28489822
[TBL] [Abstract][Full Text] [Related]
5. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.
Alvarez SE; Harikumar KB; Hait NC; Allegood J; Strub GM; Kim EY; Maceyka M; Jiang H; Luo C; Kordula T; Milstien S; Spiegel S
Nature; 2010 Jun; 465(7301):1084-8. PubMed ID: 20577214
[TBL] [Abstract][Full Text] [Related]
7. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L
Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy.
Yang KC; Ma X; Liu H; Murphy J; Barger PM; Mann DL; Diwan A
Circ Heart Fail; 2015 Jan; 8(1):175-87. PubMed ID: 25339503
[TBL] [Abstract][Full Text] [Related]
9. E3 ubiquitin ligase STUB1 affects the mTORC1 pathway through p62 and participates in regulating the differentiation of follicular helper T cells in rheumatoid arthritis.
Wang W; Yang Y; Shi Y; Xiang T; Xie J
Clin Immunol; 2023 Oct; 255():109736. PubMed ID: 37604355
[TBL] [Abstract][Full Text] [Related]
10. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma.
Dong P; Wang X; Liu L; Tang W; Ma L; Zeng W; Sun S; Zhang L; Zhang N; Shen X; Janssen HLA; Dong L; Zhang S; Chen S
J Hepatol; 2020 Dec; 73(6):1446-1459. PubMed ID: 32610114
[TBL] [Abstract][Full Text] [Related]
11. AIMP2 promotes TNFalpha-dependent apoptosis via ubiquitin-mediated degradation of TRAF2.
Choi JW; Kim DG; Park MC; Um JY; Han JM; Park SG; Choi EC; Kim S
J Cell Sci; 2009 Aug; 122(Pt 15):2710-5. PubMed ID: 19584093
[TBL] [Abstract][Full Text] [Related]
12. Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.
Pan Y; Han M; Zhang X; He Y; Yuan C; Xiong Y; Li X; Zeng C; Lu K; Zhu H; Lu X; Liu Q; Liang H; Liao Z; Ding Z; Zhang Z; Chen X; Zhang W; Zhang B
Cell Oncol (Dordr); 2022 Feb; 45(1):163-178. PubMed ID: 35089546
[TBL] [Abstract][Full Text] [Related]
13. RNF4 silencing induces cell growth arrest and DNA damage by promoting nuclear targeting of p62 in hepatocellular carcinoma.
Lv B; Pan Y; Hou D; Chen P; Zhang J; Chu Y; Li M; Zeng Y; Yang D; Liu J
Oncogene; 2022 Apr; 41(16):2275-2286. PubMed ID: 35236966
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
15. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway.
Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T
J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids: the oil on the TRAFire that promotes inflammation.
Napolitano G; Karin M
Sci Signal; 2010 Sep; 3(141):pe34. PubMed ID: 20876871
[TBL] [Abstract][Full Text] [Related]
17. Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.
Lee YH; Yoon AR; Yun CO; Chung KC
J Biol Chem; 2024 Apr; 300(4):107206. PubMed ID: 38519031
[TBL] [Abstract][Full Text] [Related]
18. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
20. K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells.
Linares JF; Duran A; Yajima T; Pasparakis M; Moscat J; Diaz-Meco MT
Mol Cell; 2013 Aug; 51(3):283-96. PubMed ID: 23911927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
